Kate Therapeutics Inc. has raised $72.8M in total funding. The most recent round was Series A.
Kate Therapeutics Inc. is headquartered in San Diego, CA.
Gene therapy company that emerged from stealth in June 2023 with a $51M Series A co-led by Westlake Village BioPartners, developing AAV-based genetic medicines for muscle and heart disease.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.